Evolent Health Announces Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Evolent Health (EVH) Tops Q3 EPS by 50c
November 2, 2022 4:29 PM EDTEvolent Health (NYSE: EVH) reported Q3 EPS of $0.62, $0.50 better than the analyst estimate of $0.12. Revenue for the quarter came in at $352.6 million versus the consensus estimate of $357.32 million.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
... More